Literature DB >> 32413222

Enno Schmidt1,2, Michael Sticherling3, Miklós Sárdy4, Rüdiger Eming5, Matthias Goebeler6, Michael Hertl5, Silke C Hofmann7, Nicolas Hunzelmann8, Johannes S Kern9, Harald Kramer10, Alexander Nast11, Hans-Dieter Orzechowski12,13, Christiane Pfeiffer14, Volker Schuster15, Cassian Sitaru9, Miriam Zidane11, Detlef Zillikens1, Margitta Worm16.   

Abstract

Year:  2020        PMID： 32413222     DOI： 10.1111/ddg.14097_g

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  6 in total

Review 1.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

Review 2.  [Geriatric dermatology].

Authors:  Marie Isolde Joura; Kamilla Koszorú; Dóra Czintner; Miklós Sárdy
Journal:  Z Gerontol Geriatr       Date:  2022-01-06       Impact factor: 1.281

Review 3.  [Bullous autoimmune dermatoses of the mucous membranes].

Authors:  Dario Didona; Julia Hinterseher; Rüdiger Eming
Journal:  Dermatologie (Heidelb)       Date:  2022-08-25

4.  Therapy Changes During Pemphigus Management: A Retrospective Analysis.

Authors:  Roberta Scarpone; Wojciech Francuzik; Margitta Worm; Guido Heine
Journal:  Front Med (Lausanne)       Date:  2020-11-25

5.  More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study.

Authors:  Ralf J Ludwig; Khalaf Kridin; Sascha Ständer; Enno Schmidt; Detlef Zillikens
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

Review 6.  Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.

Authors:  Haiqin Zhu; Meng Pan; Wenzhe Zhao; Jingying Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-04       Impact factor: 8.667
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.